Hypoplastic Left Heart Syndrome Clinical Trial
Official title:
The Impact of Family Factors on Developmental and Psychosocial Outcomes in Children With Hypoplastic Left Heart Syndrome (HLHS) at 6 Years of Age - Pediatric Heart Network Single Ventricle Reconstruction Extension (SVR II) Ancillary Study
The purpose of this study is to learn about the relationship between family factors and
developmental and psychosocial outcomes in children with congenital heart disease at 6 years
of age. A secondary purpose is to learn more about psychosocial outcomes in children with
congenital heart disease and their families over time.
About 250 mothers and fathers at 15 medical centers will take part in this study; 35 will be
from Children's Hospital of Wisconsin.
Survival for one of the most complex forms of congenital heart disease (CHD), hypoplastic
left heart syndrome (HLHS), has improved dramatically; however, survivors are known to be at
risk for both physical and psychosocial morbidity. In congenital heart disease, this
psychosocial morbidity has been manifested as delays in cognitive and social development,
behavior problems, reduced quality of life, as well as parenting stress, anxiety, and
negative impact on the family. We have a relatively limited understanding of the causes of
psychosocial morbidity and what factors may impact risk or protection for the child and
family.
The environment in which a child spends the majority of their time exerts a significant
impact on development. For infants and young children this "environment" is most commonly the
immediate family. Interactions between illness characteristics and individual family member
perceptions and expectations are an important determinant of the family's response to the
presence of heart disease in a child. There is a critical gap in our understanding of how
family-related factors influence psychosocial outcomes in the CHD population and if there are
opportunities to intervene in order to improve outcomes for both children and families.
The primary aim of this study is to investigate the relationship between family factors
including, parental mental health, parental health-related quality of life (HRQOL), family
resources, and family function, and developmental and psychosocial outcomes in children with
HLHS at 6 years of age. Secondary aims are to explore for differences in outcomes between
different family types and to establish the feasibility of longitudinal investigation of the
trajectory of child and family psychosocial function over time in this well-defined cohort of
children and parents.
Longitudinal assessment of these family factors, in conjunction with neurodevelopmental and
psychosocial evaluation of affected children, will provide improved understanding of how and
when these factors influence child development. This will help to:
- Identify children/families at risk for problems,
- Elucidate the etiology and progression of psychosocial problems in children with
congenital heart disease,
- Describe the relationships between child and family outcomes over time, and guide the
development of family-focused interventions with a goal of preventing problems.
This study will be conducted as an ancillary study to the Single Ventricle Reconstruction
Extension Study (SVR II) conducted by the Pediatric Heart Network (PHN). All PHN study sites
will be eligible to participate in this study. Participation will be determined by the PHN
principal investigator at each site. Parents of children enrolled in SVR II will be eligible
to participate in this ancillary study.
A multivariable, descriptive design using survey techniques will be utilized. Mothers and
fathers of children with HLHS will complete study measures at or near the SVR II 6 year
visit. Correlation, regression, and structural equation modeling will be used to test study
hypotheses.
Results of this study have the potential to better define the family implications of this
disease, the risk factors for poor outcomes and ultimately, to guide development of
interventions to improve child and family psychosocial outcomes.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01215240 -
Prophylactic Peritoneal Dialysis Decreases Time to Achieve a Negative Fluid Balance After the Norwood Procedure
|
N/A | |
Completed |
NCT00513240 -
Erythropoetin Neuroprotection for Neonatal Cardiac Surgery
|
Phase 1/Phase 2 | |
Withdrawn |
NCT00156455 -
Sleep Disordered Breathing in Children With Single Ventricle Physiology
|
N/A | |
Terminated |
NCT01445041 -
Safety and Feasibility Study of Umbilical Cord Blood Cells for Infants With Hypoplastic Left Heart Syndrome
|
Phase 1 | |
Recruiting |
NCT04581668 -
Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease
|
N/A | |
Completed |
NCT01736956 -
Fetal Intervention for Aortic Stenosis and Evolving Hypoplastic Left Heart Syndrome
|
N/A | |
Completed |
NCT01708863 -
A Prospective Study of Patients With Hypoplastic Left Heart Syndrome (HLHS) Following Stage II Surgical Palliation
|
||
Recruiting |
NCT03406884 -
The CHILD Trial: Hypoplastic Left Heart Syndrome Study.
|
Phase 1 | |
Not yet recruiting |
NCT06461676 -
Study of Intramyocardial Injection of Ventrix Bio Extracellular Matrix (VentriGel) to Assess the Safety and Feasibility in Pediatric Patients With Hypoplastic Left Heart Syndrome (HLHS)
|
Phase 1 | |
Active, not recruiting |
NCT03079401 -
Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle
|
Phase 1/Phase 2 | |
Completed |
NCT02306057 -
Fluid Balance in Children Undergoing Fontan Surgery
|
N/A | |
Terminated |
NCT01107990 -
Global and Regional Myocardial Strain and Power Output In Patients With Single Ventricles Using Novel MRI Techniques
|
||
Completed |
NCT01883076 -
Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome
|
Phase 1 | |
Completed |
NCT04056416 -
Physical Activity Promotion in Children and Adolescents With Single Ventricle Physiology (MedBike)
|
N/A | |
Completed |
NCT01656941 -
Genetic Determinants of Congenital Heart Disease Outcomes
|
||
Completed |
NCT00464100 -
Near-infrared Spectroscopy (NIRS) Neurodevelopmental Outcomes
|
||
Active, not recruiting |
NCT03779711 -
Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome
|
Phase 2 | |
Recruiting |
NCT04925024 -
Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.
|
Phase 2 | |
Recruiting |
NCT02781922 -
Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial)
|
Phase 3 | |
Completed |
NCT00974025 -
Impact of Vitamin C on Endothelial Function and Exercise Capacity in Fontan-Palliated Patients
|
N/A |